U.S. Auto Stock News

UBS’ decision to downgrade Perimeter Solutions (PRM) from Buy to Neutral, while the company funds its Medical Manufacturing Technologies acquisition through a $550 million note offering, has put the stock’s risk and return trade off in sharper focus. See our latest analysis for Perimeter Solutions. At a share price of $28.08, Perimeter Solutions has seen a 24.58% 3 month share price return and a 116.33% 1 year total shareholder return. This suggests recent momentum remains positive even as...

Western Digital’s recent spin-off of its flash business and sharpened focus on hard disk drives for data centers have intersected with bullish trading signals, including repeated tests of a key technical resistance level and strong order-flow “Power Inflow” alerts earlier this month. This combination of a more specialized business model and concentrated buying activity highlights how AI-driven data center demand and hyperscaler spending are increasingly central to Western Digital’s current...

If you are wondering whether Zai Lab's current share price lines up with its underlying worth, this article walks through the numbers so you can form your own view. Zai Lab's stock closed at US$18.72, with returns of 2.9% over the last 7 days, 5.3% over the last 30 days and 8.0% year to date, while the 1 year, 3 year and 5 year returns stand at a 22.9% decline, 58.5% decline and 89.9% decline respectively. Recent share price moves sit against an ongoing flow of company updates and sector...

Wealthfront (WLTH) just posted its Q3 2026 numbers, with revenue of US$93.2 million, basic EPS of US$0.72 and trailing twelve month EPS of US$3.04 setting the backdrop for the quarter. The company has seen revenue move from US$80.3 million in Q3 2025 to US$93.2 million in Q3 2026, while quarterly EPS has shifted from US$0.77 to US$0.72 over the same period, against trailing twelve month revenue of US$351.5 million. With a current net profit margin of 35.2% versus 57.7% a year ago, this update...

Morgan Stanley recently initiated coverage on GRAIL (GRAL.US) with a hold rating, as analyst Kallum Titchmarsh issued his first formal view on the company. This new coverage introduces an additional institutional lens on GRAIL’s multi-cancer early detection business, potentially shaping how investors interpret its risk‑reward profile. We'll now examine how Morgan Stanley's new hold rating interacts with expectations for Galleri adoption, profitability paths, and long-term earnings...

If you are wondering whether Intercontinental Exchange at around US$166 per share offers reasonable value today, the key is understanding how its current price lines up with different valuation yardsticks. The stock has recently posted returns of 0.4% over 7 days, 2.1% over 30 days, 4.2% year to date, 16.1% over 1 year, 61.3% over 3 years, and 54.7% over 5 years, which gives useful context for how the market has been pricing its prospects and risks. Recent coverage around Intercontinental...

Wondering if Celsius Holdings is still reasonably priced after its strong run, or if the value case is already played out? This article is built to help you size that up with clear valuation checks. The stock last closed at US$52.61, with returns of 8.1% over 7 days, 20.0% over 30 days, 10.2% year to date and 95.8% over 1 year, which naturally raises questions about how much future upside or risk is already reflected in the price. Recent attention on Celsius has centered on its position in...

Eos Energy Enterprises recently hosted its “Eos in Focus” event on January 14, where management reviewed full-year 2025 financial and operating results and outlined its business outlook for 2026. This update is important because it gives investors fresh detail on how Eos’s scale-up and technology roadmap are progressing against its long-term plans. We’ll now examine how the fresh operational and 2026 outlook detail from “Eos in Focus” could influence Eos’s investment narrative. The latest...

Conference spotlight and product news put Elanco in focus Elanco Animal Health (ELAN) is drawing fresh attention after securing U.S. Department of Agriculture approval for its new canine dermatitis treatment, Befrena, and outlining its plans ahead of its J.P. Morgan Healthcare Conference appearance. See our latest analysis for Elanco Animal Health. Those product updates and the J.P. Morgan appearance come as Elanco’s share price sits at $24.45, with a 30 day share price return of 14.84% and a...

TransMedics Group (TMDX) has committed to a long-term lease for a new global headquarters at Assembly Innovation Park in Somerville, and it has acquired adjacent land to build an integrated campus and expand its transplant therapy operations. See our latest analysis for TransMedics Group. The headquarters announcement follows a period of strong recent momentum, with a 1-day share price return of 5.98% lifting TransMedics Group to US$142.71 and contributing to a 30-day share price return of...

Ciena recently delivered fiscal fourth-quarter results that surpassed analyst expectations and issued optimistic fiscal 2026 guidance, highlighting anticipated revenue growth and stronger operating margins. The CEO also emphasized Ciena’s reinforced position in high-speed connectivity and its growing role in AI-related network infrastructure, underscoring the company’s importance in supporting data-intensive workloads. We’ll now examine how Ciena’s stronger-than-expected quarter and upbeat...

In early January 2026, Nuvation Bio Inc. and Eisai Co. Ltd. announced an exclusive license and collaboration agreement granting Eisai rights to develop, register and commercialize taletrectinib (IBTROZI) for ROS1-positive non-small cell lung cancer across Europe, large parts of Asia-Pacific, the Middle East, North Africa, Russia, Turkey, Canada, Australia, New Zealand and India, in return for an upfront payment of €50 million (about US$60 million), up to €145 million (about US$170 million)...

If you are wondering whether Marriott International's share price still reflects fair value after a strong run, you are not alone. The stock last closed at US$322.96, with returns of 0.3% over 7 days, 8.1% over 30 days, 3.0% year to date, 18.0% over 1 year and 106.7% over 3 years, while the 5 year return stands at 164.0%. Recent coverage of Marriott has focused on its position as a major global hotel operator and how investors are thinking about long term travel demand and corporate travel...

Apellis Pharmaceuticals (APLS) has drawn fresh attention after reporting preliminary 2025 U.S. net product revenue of about US$689 million, led by demand for SYFOVRE, along with early EMPAVELI uptake and new pipeline updates. See our latest analysis for Apellis Pharmaceuticals. Despite the revenue update and ongoing work on SYFOVRE and EMPAVELI, Apellis’ share price has come under pressure, with a 30 day share price return of a 15.46% decline and a 1 year total shareholder return of a 22.97%...

Recent analyst upgrades on Sea (SE) have put fresh attention on the stock after a pullback from its 2025 high, highlighting how Shopee’s VIP program and fulfillment investments might reshape the risk reward profile for investors. See our latest analysis for Sea. Sea’s shares have been under pressure recently, with a 7 day share price return of 9.12% and a 90 day share price return of 20.54%. This is occurring even though the 1 year total shareholder return is 17.58% and the 3 year total...

Yum! Brands (YUM) has drawn fresh attention after launching a review of options for its Pizza Hut division, including a potential divestment, just as the company heads into its upcoming fourth quarter earnings release. See our latest analysis for Yum! Brands. The Pizza Hut review and upcoming earnings have arrived after a solid run in the shares, with Yum! Brands posting an 8.2% 90 day share price return and a 27.8% one year total shareholder return, suggesting momentum has been building into...

In early January 2026, lululemon athletica raised its outlook for the fourth quarter of fiscal 2025, saying net revenue and diluted earnings per share should come in toward the high end of prior ranges of US$3.50 billion to US$3.59 billion and US$4.66 to US$4.76, respectively. Management linked this stronger guidance to better-than-expected holiday demand, even as the company works through leadership changes and a reset of its U.S. business. We’ll now examine how this holiday-driven guidance...

Village Farms International (VFF) has drawn fresh attention after its Leli Holland unit rolled out ten new cannabis products into the regulated Dutch market, including the country’s first licensed blunt and several tailored spliff formats. See our latest analysis for Village Farms International. At a share price of $3.50, Village Farms International has seen a 30 day share price return decline of 14.22% and a year to date share price return decline of 5.15%. Its 1 year total shareholder...

Piper Sandler recently upgraded Arista Networks to a more positive rating, citing improving business visibility tied to enterprise IT spending and demand from hyperscale and AI-focused customers. Separately, Fortinet’s announcement of a jointly developed Secure AI Data Center solution with Arista underscores Arista’s role in integrated networking and security for emerging AI infrastructure. We’ll now examine how improving visibility into AI‑related demand and enterprise spending could...

D&H’s new partnership with Fortinet (FTNT) brings the full Fortinet security suite into the D&H Advanced Solutions+ ecosystem, expanding Fortinet’s reach across U.S. channel partners and drawing fresh attention to the stock’s setup. See our latest analysis for Fortinet. Against this backdrop, Fortinet’s share price has been soft in the near term, with a 30 day share price return showing a 4.73% decline and a 90 day share price return showing a 6.28% decline. The current 1 year total...

In early January 2026, Jefferies downgraded First Solar to Hold, citing lowered guidance, significant de-bookings, margin pressure, and limited deployment opportunities in 2026 amid tougher market conditions. At the same time, other banks reaffirmed positive views on First Solar, underscoring how divided analyst opinions have become over the company’s outlook and risks. We’ll now examine how Jefferies’ concerns about weakened bookings and compressed margins could influence First Solar’s...

Veeco Instruments (VECO) has drawn fresh attention after recent share price moves, with the stock showing double digit returns over the past month and past 3 months. That shift is prompting closer scrutiny from semiconductor investors. See our latest analysis for Veeco Instruments. Veeco’s recent momentum, including an 11.56% 1 month share price return and 17.51% 3 month share price return, sits alongside a 30.13% 1 year total shareholder return and a 68.77% 3 year total shareholder return...

Bristow Group Inc. recently completed a private offering of US$400 million in senior secured notes due 2033, guaranteed by key subsidiaries and secured against helicopters and other operating assets, to fund the full redemption of its existing 6.875% senior secured notes due 2028. This refinancing reshapes Bristow’s debt profile by extending maturities and pledging approximately 70 aircraft as collateral, an important shift for a capital-intensive aviation services business. Next, we’ll...

In January 2026, the U.S. Department of Energy selected Centrus Energy for a US$900 million task order to expand its Piketon, Ohio uranium enrichment facility for commercial-scale High-Assay, Low-Enriched Uranium (HALEU) and additional Low-Enriched Uranium production, supporting thousands of jobs across Ohio, Tennessee, and a nationwide supplier network. This award reinforces Centrus Energy’s role as a key U.S. uranium enricher at the center of efforts to rebuild domestic nuclear fuel supply...